对新型抗血小板药物的领悟：…
因此抗血小板药物在ACS治疗中有着重要的地位。
Antiplatelet agents play an important role in the treatment of ACS.
如果你对阿司匹林过敏，其他抗血小板药物可供选择。
If you are allergic to aspirin, other anti-platelet medicines are available.
【摘要】目的综述抗血小板药物的应用现状和研究进展。
Abstract Objective Summary of Application Status and Progress of antiplatelet drugs.
背景：氯吡格雷是一种导致凝血时间延长的抗血小板药物。
Background: Clopidogrel is an anti-platelet agent which causes an increase in bleeding time.
但是这些抗血小板药物也增加出血的风险，包括上消化道出血。
But these antiplatelet drugs also increase the risk of bleeding, including upper GI bleeding.
结论在当前高龄男性内科住院患者中，抗血小板药物应用不满意。
Conclusion Anti-platelet drugs were underused in the patients who had indications.
大量研究已显示，抗血小板药物能得到减少DM缺血性事件的临床获益。
Numerous studies have shown the clinical benefit of antiplatelet agents in reducing ischemic events in DM patients.
本文介绍了常用抗血小板药物的作用机制以及指南性建议和临床试验证据。
This article introduces the mechanism of currently available antiplatelet drugs as well as their practice guidelines and evidence from clinical trials.
我觉得，三重治疗并不能解决问题，而应该选择其他可选择的抗血小板药物。
In my opinion, it is not with triple therapy that we can solve this problem but with alternative antiplatelet agents.
最大的变化是抗血小板药物的使用率增加，比如双重抗血小板治疗以及抗凝治疗。
The biggest change has been in the increased use of international therapy and anti-platelet agents as dual anti-platelet therapy, and antithrombotics.
因此，对于除阿司匹林之外的抗血小板药物药物的应用，选择合适的患者是重要的。
Therefore, selection of patients who might benefit from antiplatelet therapy other than aspirin is important.
抗血小板药物(例如波利维)被用来帮助预防伴心脏病人群中潜在有危险性的血栓形成。
Antiplatelet drugs, such as Plavix, are used to help prevent potentially dangerous blood clots from forming in people with heart disease.
目的：观察舒心饮与抗血小板药物联合应用对冠状动脉支架血栓等术后冠脉事件的预防作用。
Objective: To evaluate the preventive effect of antiplatelet regimens and it′s combination with Shuxinyin (SXY) on coronary events including stent thrombosis after stenting implantation.
血小板功能检测对于临床相关疾病的诊断和抗血小板药物的筛选及相关研究有着重要的意义。
The platelet function assays have values in the investigating patients with suspected platelet disorders and in studying the effects of anti-platelet drugs.
然而，尽管抗血小板药物达到了临床获益，但DM出现缺血性事件的风险仍大于非dm的风险。
However, despite the clinical benefit achieved with antiplatelet agents, patients with DM continue to have an increased risk of ischemic events compared to non-DM.
抗血小板药物通过阻断不同的作用位点抑制血小板聚集，从而达到预防及治疗血栓性疾病的作用。
They can through different sites of action blocking platelet gathered, so as to achieve the role of prevention and treatment of thrombotic disorders.
联合应用氯吡格雷和其他抗血小板药物，已经越来越多出现在的急性股骨颈骨折患者的医疗处方中。
An increasing number of patients presenting with an acute femoral neck fracture take clopidogrel in combination with other anti-platelet agents as regular prescription medication.
目的：探讨下肢深静脉血栓介入治疗中形成急性血栓，应用新型抗血小板药物替罗非班的临床价值。
Objective: To study the application value of neotype antiplatelet drug tirofiban in the interventional therapy of lower extremity deep venous thrombosis after acute thrombosis was formed.
联合用药不增加出血性并发症的风险，因此表明双嘧达莫可能有除作为抗血小板药物外的另一种作用。
The risk of major bleeding complications is not increased with the combination, which suggests that dipyridamole might act in another way than as antiplatelet drug.
我还想特别指出一些试验，这些试验观察了新型抗凝药物和抗血小板药物用于急性冠脉综合征或PCI。
I would also like to highlight some other trials based on their use of new anti-coagulant and anti platelet agents either in the setting of acute coronary syndrome or PCI including the AVERROES trial.
不同的抗血小板药物对PLA形成的影响有所差异，监测pla有助于指导抗血小板药的临床应用和筛选。
The PLA formation is affected variously by various antiplatelet agents. Monitoring of PLA formation is helpful in guiding the clinical use and selection of antiplatelet agents.
有可能，根据一项研究发现：当患者停用了常用抗血小板药物波立维后，心脏突发事件或死亡率会突然增长。
Perhaps, according to a study that found the risk of heart attack or death jumped when patients went off the popular blood thinner Plavix.
对于伴有主动脉弓活动性血栓的不明原因卒中患者，建议或者口服抗凝，或者服用抗血小板药物(2c级)。
For patients with cryptogenic stroke associated with mobile aortic arch thrombi, we suggest either oral anticoagulation or antiplatelet agents (Grade 2c).
但是近期的报道已经表明两种药物之间有潜在危险的相互作用，由此质子泵抑制剂降低抗血小板药物的实际效果。
But recent reports had suggested that there might be a potentially dangerous interaction between the two drug classes whereby PPIs reduce the actual effectiveness of antiplatelet agents.
本文介绍了抗血小板聚集药物的研究概况，并对抗血小板药物帕米格雷的药代动力学和药效学特征作了简要综述。
The development of anti-platelet agents was described in this paper. Pamicogrel, a new anti-platelet drug, was introduced in detail, including its pharmacokinetics and pharmacodynamics.
方法运用药学监护的一般方法，对患者的病情评估、抗凝药物与抗血小板药物的选择、药物相互作用进行药学监护。
Methods using the way of pharmaceutical care, and evaluation of the patient, the choice of anticoagulation and antiplatelet drugs, drug interaction for pharmaceutical care.
前言： 目的：对2005-2006年上海市东方医院抗血小板药物用药合理性进行调查分析，为合理用药提供参考。
Objective: To investigate the rational use of antiplatelet drugs in Shanghai East Hospital during 2005-2006 in order to offer the reference to clinical utilization of the drugs.
许多2型糖尿病对普通剂量的抗血小板药物反应性降低，但是加大P2Y12阻断剂的剂量后可能会克服这种耐药现象。
Many type 2 diabetes mellitus show a decreased responsiveness to a common dose of the clopidogrel, the drug resistance may be overcome by applying higher doses of the P2Y12 antagonist.
许多2型糖尿病对普通剂量的抗血小板药物反应性降低，但是加大P2Y12阻断剂的剂量后可能会克服这种耐药现象。
Many type 2 diabetes mellitus show a decreased responsiveness to a common dose of the clopidogrel, the drug resistance may be overcome by applying higher doses of the P2Y12 antagonist.
应用推荐